AIRSUPRA
SABAICS MDI
Albuterol / Budesonide · AstraZeneca
Active Medication & Mechanism
- Albuterol sulfate SABA90 mcg albuterol per actuation
Short-acting beta2-adrenergic agonist. Relaxes bronchial smooth muscle by activating beta2-receptors, increasing cAMP, and producing rapid bronchodilation within minutes.
- Budesonide ICS80 mcg per actuation
Corticosteroid with anti-inflammatory properties. Reduces airway inflammation and edema to help prevent worsening of symptoms during acute episodes.
FDA-Approved Dosing by Indication
// approval varies by strength + age Asthma
1/1 approved regimens| Strength | Population | Dose & Frequency | Total Daily | Status |
|---|---|---|---|---|
| 90/80 mcg | Patients ≥18 years | 2 inhalations as needed for bronchoconstriction symptoms For the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in adults with asthma. Not for scheduled maintenance use. | Maximum 12 inhalations (1080/960 mcg) per 24 hours | FDA Approved |